Literature DB >> 26706172

α-Aryl pyrrolidine sulfonamides as TRPA1 antagonists.

Vishal A Verma1, Daniel G M Shore1, Huifen Chen1, Jun Chen1, Steven Do1, David H Hackos1, Aleks Kolesnikov1, Joseph P Lyssikatos1, Suzanne Tay1, Lan Wang1, Anthony A Estrada1.   

Abstract

A series of α-aryl pyrrolidine sulfonamide TRPA1 antagonists were advanced from an HTS hit to compounds that were stable in liver microsomes with retention of TRPA1 potency. Metabolite identification studies and physicochemical properties were utilized as a strategy for compound design. These compounds serve as starting points for further compound optimization.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ion channel; Metabolic stability; TRPA1

Mesh:

Substances:

Year:  2015        PMID: 26706172     DOI: 10.1016/j.bmcl.2015.11.088

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  1 in total

1.  Translational and pharmacokinetic-pharmacodynamic application for the clinical development of GDC-0334, a novel TRPA1 inhibitor.

Authors:  Phyllis Chan; Han Ting Ding; Bianca M Liederer; Jialin Mao; Paula Belloni; Liuxi Chen; Simon S Gao; Victory Joseph; Xiaoying Yang; Joseph S Lin; Mayur S Mitra; Wendy S Putnam; Angelica Quartino; Rebecca N Bauer; Lin Pan
Journal:  Clin Transl Sci       Date:  2021-05-31       Impact factor: 4.689

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.